您当前的位置:
首页 >
文章列表页 >
Bridging the lung cancer screening eligibility gap: evaluation of guideline applicability in asymptomatic patients
Bridging the lung cancer screening eligibility gap: evaluation of guideline applicability in asymptomatic patients
Bridging the lung cancer screening eligibility gap: evaluation of guideline applicability in asymptomatic patients
- “一项中国多中心研究介绍了其在肺癌筛查优化方面的研究进展。研究人员建立了筛查资格的时间趋势,为解决严格的USPSTF标准忽视大量高危人群的问题提供了解决方案,并为构建个性化风险分层系统奠定了基础。”
- 军事医学研究(英文) 2026年13卷第9期 页码:1399-1416
DOI: 10.1016/j.mmr.2026.100020
录用:2026-03-05
移动端阅览
AI导读
HTML全文
图( 4 ) 表( 3 )
参考文献
出版信息
数据统计
16
浏览量
53
下载量
0
CSCD
文章被引用时,请邮件提醒。
提交
工具集
- BibTeX下载
- Endnote下载
- RefMan 下载
- NoteExpress下载
- NoteFirst下载
相关文章
Are metformin-based combination approaches beneficial for non-small cell lung cancer: evidence from experimental and clinical studies
Treatment of malignant airway obstruction with intrabronchial microwave tissue coagulation in combination with Ir192 radiation
Endothelial barrier and sepsis: mechanisms and potential therapeutic strategies
Engineering of functional auditory neurons from human induced pluripotent stem cells
Maladaptive reorganization of mediodorsal thalamus as a central mechanism in neuropathic pain-related sleep disorders
相关作者
Ravi P. Sahu
Vaibhav Gajjar
Anita Thyagarajan
Jie Fan
Jing-jing Ji
相关机构
Department of Pharmacology and Toxicology, Boonshoft School of Medicine Wright State University
McGowan Institute for Regenerative Medicine, University of Pittsburgh
Research and Development, Veterans Affairs Pittsburgh Healthcare System
Department of Pathophysiology, Southern Medical University
Department of Surgery, University of Pittsburgh School of Medicine

